An Emulated Target Trial Case Study of Real‐World Overall Survival With Second‐Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer

Documenti analoghi

• Comparative Survival of First‐Line Immunotherapy Plus Chemotherapy Versus Immunotherapy Monotherapy in Older Adults With Metastatic Non‐Small Cell Lung Cancer: An Emulated Target Trial Approach
  di: Xiangzhong Xue, et al.
  Pubblicazione: (2026)
• Resumption of Antiplatelet Therapy After Burr‐Hole Surgery and Recurrence in Patients With Chronic Subdural Hematoma: A Target Trial Emulation
  di: Takayuki Anno, et al.
  Pubblicazione: (2026)
• Vancomycin‐Induced Acute Kidney Injury in Intensive Care Patients: A Target Trial Emulation Study Using Multicenter Routinely Collected Data
  di: Izak A. R. Yasrebi‐de Kom, et al.
  Pubblicazione: (2025)
• Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second‐Line Treatment of Advanced Non–Small Cell Lung Cancer
  di: Euloge Clovis Kenne Pagui, et al.
  Pubblicazione: (2025)
• Safety and Effectiveness of Apixaban Versus Rivaroxaban in Atrial Fibrillation Patients in Singapore: An Active‐Comparator, New‐User Cohort study
  di: Aaron Jun Yi Yap, et al.
  Pubblicazione: (2026)